United Arab Emirates: France will have a strong presence at Arab Health 2021, bringing 51 businesses to further herald its medical expertise. Located in the French Healthcare pavilion organized by Business France in Za’abeel Hall 2 and Sheikh Rashid Hall, they will unveil their latest innovations designed to take up major challenges in healthcare.
French Healthcare shows off its strong medtech expertise at Arab Health 2021
As a high point for innovation at Arab Health every year, French Healthcare businesses have formed strong bonds with countries in the region over recent years. France enjoys an excellent reputation, not only for its innovation capacity but also for the partnerships and commercial relations it sustains with Middle Eastern firms.
The most represented sectors in 2021 at the French Healthcare pavilion are consumer goods, diagnostic tests, digital health, hospital and medical equipment, medical gas equipment, orthopedics and physiotherapy/rehabilitation.
Among the French healthcare businesses, the following businesses will be displaying their newest solutions: Sublimed (treatment of chronic pain), Lamidey Noury (a leading French manufacturer of electrosurgical solutions), Noraker (reconstruction of patients after orthopedic or dental surgery), TMM Software (digitalization of patients pathway), Hoppen (digital solutions for healthcare centers), Chronolife (Predictive artificial intelligence of patients’ health status) and Scaleo Medical (innovative medical devices).
French Healthcare: a collective brand to merge the strengths of the French ecosystem globally
French Healthcare is a public-private initiative aimed at bringing together French businesses, researchers and healthcare professionals to jointly promote their activities, expertise, technologies and innovations internationally. Amongst its numerous fields of competence, France stands out in patient care, oncology, surgical devices, orthopedics, radiology, treatment of medical waste, sterilization and disinfection, to name just a few.
An all-new website!
To promote the many advantages of the French healthcare industry, French Healthcare has launched a new website, with the latest news, events and innovations in pharma, biotech, medtech and digital health. If you are looking to get innovative solutions, get mappings of French solutions, get medical treatment or training in France, develop a business, medical or scientific partnership with a French firm, or invest in France, please visit: www.frenchhealthcare.fr.
Re-inventing oncology through French Healthcare excellence
France stands out around the world, thanks to its effective and innovative healthcare solutions to fight cancer. It has one of the best cancer cure rates and is positioned as a leader in cancer research, with more than 130 research projects and 13 Nobel Prizes in medicine. France is recognized the world over for its excellence in oncology, the top quality of its infrastructures using cutting-edge technologies, its longstanding expertise in care, patient management (prevention, diagnosis and treatment) and research, as well as for its global approach to oncology, offering industrial, technical and scientific expertise. Oncology is the leading therapeutic area of the French HealthTech industry.
To highlight French expertise and innovative solutions in the field of oncological treatment, the French Healthcare Association and Business France have organized a webinar available on-demand on the Main Stage of the Arab Health – Swapcard platform:
French excellence in this medical branch extends well beyond the field of medicine to encompass pharmaceuticals, biotechnologies, medtech and its pool of digital health players, spearheading French startups in the health sector. To reveal the breadth of this expertise, the French Healthcare Association and Business France have published a Cancer Map, which highlights all the French solutions in the field of oncological treatment: consultancy and training expertise, organizational and industrial solutions, partnerships for research, medical training for foreign professionals in France and treatment of international patients in France.
France: a cutting-edge world-class player in medical industry
The swiftness and scale of the Covid-19 pandemic cast the light on the crucial importance of scientific and medical innovation. It also offered a reminder of the importance of global public health issues in prevention, diagnosis and therapeutic innovation. France is one of the key players in this dynamic and has many key strengths that form the architecture of an efficient and innovative health system. If France is now recognized as having designed one of the most successful and equitable public health models in the OECD, it is because it has long built up a training system premised on excellence for healthcare professionals, hailed worldwide for their expertise. France’s basic research is also internationally renowned for the avant-gardism and importance of its work, while its pharmaceutical industry forms another major pillar of France’s medical excellence, through the role played by its first-rate international players combined with the innovation dynamics of the startup ecosystems and SMEs established across the country.
With more than 1,500 businesses, mostly (93%) SMEs, and €30 billion in annual revenues, including €9 billion from exports – an increase of 10% between 2017 and 2019 – France is the second biggest market in Europe. These firms of all sizes employ nearly 90,000 people working in a large number of fields, such as e-health, surgical robotics, telemedicine, optical technologies, wound healing, medical imaging and many more. The key to the French medtech successes is innovation and R&D. With 3,750 patents per year, France is ranked fifth in the world for the filing of international patents in the medical device sector. (source: SNITEM, 2019)
In the United Arab Emirates, France is the fourth largest supplier of pharmaceutical products and has developed substantial economic and commercial activity, with many subsidiaries already established in the health sector, such as Sanofi, Ipsen, Servier, Air Liquide and Hygienair.
France: an attractive destination for healthcare businesses to expand or invest
France has set the ambition of becoming the leading nation for industry and innovation in healthcare. To strengthen its position as a global hub for healthtech and to become the leading European nation for healthcare, France, which already has a strong export industry, wants to welcome foreign businesses and has developed an active policy to attract them. The aim is to reinforce the growth of a positive healthcare ecosystem and, in so doing, dynamize the development of each of its stakeholders.
Follow French Healthcare on social media to keep up-to-date with the latest news, events and opportunities
© Press Release 2021
Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.
The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.
To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.